Johnson & Johnson's single-dose Covid-19 vaccine received emergency use approval from the U.S. FDA late last week, with a rollout expected to begin shortly. So what does this mean for J&J's stock? Overall, the vaccine isn't expected to really move the needle for J&J's bottom line, as it intends...
Johnson & Johnson's single-dose Covid-19 vaccine received emergency use approval from the U.S. FDA late last week, with a rollout expected to begin shortly. So what does this mean for J&J's stock? Overall, the vaccine isn't expected to really move the needle for J&J's bottom line, as it intends...
Share this Article
Recommended